AIFSIDDES: Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals
Sponsor
Liuhuaqiao Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00973375
Collaborator
(none)
30
1
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Study Start Date
:
May 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Endeavor group and Excel group Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s). |
Outcome Measures
Primary Outcome Measures
- Segment and instent restenosis measured by coronary angiography and IVUS. [at 12 months after implantation]
Secondary Outcome Measures
- Uncovered and malposition of stent. [at 12 months after implantation.]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.
Exclusion Criteria:
- Dual anti-platelet therapy less than 12 months.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Liuhuaqiao Hospital | Guangzhou | Guangdong | China | 510010 |
Sponsors and Collaborators
- Liuhuaqiao Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Lee CH, Zhang J, Kailasam A, Tai BC, Ye F, Low AF, Hou X, Hay ET, Teo SG, Lim YT, Chen S, Tan HC. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden. J Interv Cardiol. 2008 Dec;21(6):519-27. doi: 10.1111/j.1540-8183.2008.00397.x. Epub 2008 Oct 21.
- Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ; ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008 Jan;155(1):108-13. Epub 2007 Sep 14.
- Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015.
Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00973375
Other Study ID Numbers:
- LHQ09-003
First Posted:
Sep 9, 2009
Last Update Posted:
Sep 9, 2009
Last Verified:
Sep 1, 2009